Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carol A Langford, MD, MHS
The Cleveland Clinic
Principal Investigator - Jeffrey P Krischer, PhD
University of South Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- University of British Columbia, St. Paul'S Rheumatology Clinic
Vancouver, British Columbia, Canada
- St. Joseph'S Hospital, Hamilton
Hamilton, Ontario, Canada
- Mount Sinai Hospital, Toronto
Toronto, Ontario, Canada
- Medius Kliniken
Kirchheim unter Teck, Germany
- St. Vincent'S University Hospital
Dublin, Ireland
- University of Aberdeen
Aberdeen, United Kingdom
- University of Cambridge- Addenbrookes Hospital
Cambridge, United Kingdom
- Nottingham University Hospitals
Nottingham, United Kingdom
- Royal Berkshire Hospital
Reading, United Kingdom
- Cedars Sinai Medical Center, Los Angeles
Los Angeles, California, United States
- University of South Florida Rheumatology
Tampa, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Hospital for Special Surgery
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Apr 2015
- Primary completion
- 25 Jul 2023
- Completion
- 20 Dec 2023
- Last update posted
- 29 Jul 2024
- Registered enrollment
- 65
- Registry id
- NCT02108860
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.